SIRACUSA

Ipsen Biopharm Limited

Application Filed: 2018-04-20
Trademark Application Details
Trademark Logo SIRACUSA
641
Live/Pending
NON-FINAL ACTION - MAILED
Research OneLook Acronym Finder
Serial Number87886335
Registration Number6004952
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic RepresentativeFrances M. Jagla
Attorney NameFrances M. Jagla
Attorney Docket Number130785.0047
Law Office AssignedM10
Employee NameKHOURI, SANI PHILIPPE

Timeline

2018-04-20Application Filed
2019-05-05Location: TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
2019-05-05Status: Live/Pending
2019-10-25Transaction Date
2019-12-24Published for Opposition
2020-03-10Trademark Registered

Trademark Applicants & Owners

Owner: Ipsen Biopharm Limited
AddressAsh Road, Wrexham Industrial Estate Wrexham GB LL139UF
Legal Entity TypeCorporation
Legal Entity State GB

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Frances M. Jagla
LANE POWELL PC
1420 Fifth Avenue, Suite 4200
Seattle WA 97204

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0051Pharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroenterology, and for cardiovascular and cognitive disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders, muscle disorders orthopedic disorders, disorders relating to age; pharmaceutical preparations for the treatment of pain, muscle spasm, hemifacial spasm and blepharospasm; pharmaceutical preparations for the treatment and prevention of cervical dystonia, torticollis, cerebral palsy, and spasticity; pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for use in the treatment of excessive sweating, neuromuscular disorders, muscle disorders, orthopedic disorders, disorders relating to age, pain, muscle spasm, hemifacial spasm and blepharospasm, cervical dystonia, torticollis, cerebral palsy, and spasticity, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin
GS0051Pharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroenterology, and for cardiovascular and cognitive disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders, muscle disorders orthopedic disorders, disorders relating to age; pharmaceutical preparations for the treatment of pain, muscle spasm, hemifacial spasm and blepharospasm; pharmaceutical preparations for the treatment and prevention of cervical dystonia, torticollis, cerebral palsy, and spasticity; pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for use in the treatment of excessive sweating, neuromuscular disorders, muscle disorders, orthopedic disorders, disorders relating to age, pain, muscle spasm, hemifacial spasm and blepharospasm, cervical dystonia, torticollis, cerebral palsy, and spasticity, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2018-04-241 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-05-012 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2018-08-103 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2018-08-134 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2018-08-135 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED2018-08-136 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-02-127 TROA I:Incoming Correspondence
ASSIGNED TO LIE2019-02-198 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-02-229 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2019-02-2210 TEME I:Incoming Correspondence
NON-FINAL ACTION WRITTEN2019-03-1511 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2019-03-1512 GNRT O:Outgoing Correspondence
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-03-1513 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-04-1514 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-04-2215 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2019-04-2216 TEME I:Incoming Correspondence
NON-FINAL ACTION WRITTEN2019-05-0517 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2019-05-0518 GNRT O:Outgoing Correspondence
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-05-0519 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-10-2520 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-11-0421 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2019-11-0422 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2019-11-2023 CNSA O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-12-0424 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2019-12-2425 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-12-2426 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER2020-03-1027 R.PR A:Allowance for Publication

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed